Biodexa Pharmaceticals (BDRX)
Earnings
Annual and quarterly EPS data presented alongside analyst estimates, earnings surprises, and historical growth statistics. The side-by-side view of reported versus estimated EPS — combined with surprise percentage and report timing — allows investors to assess whether a company consistently beats, meets, or misses market expectations, and how that track record has evolved across full economic cycles.
Earnings annual
Fiscal date endingReported EPS
Dec 31, 2025
-1044250.0199
Mar 31, 2026
0
Jun 30, 2026
0
Calculation
Growth rate
100.00%
Average
-348,083.34
Maximum
Jun 30, 2026
0
Minimum
Dec 31, 2025
-1044250.0199
Median
Mar 31, 2026
0
Earnings quarterly
| Fiscal date ending | Sep 30, 2017 |
| Reported date | Nov 29, 2017 |
| Report time | PRE_MARKET |
| Reported EPS | -82.14 |
| Estimated EPS | 0 |
| Surprise | -82.14 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2018 |
| Reported date | Jun 29, 2018 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Jun 30, 2018 |
| Reported date | Sep 27, 2018 |
| Report time | PRE_MARKET |
| Reported EPS | -64.07 |
| Estimated EPS | 0 |
| Surprise | -64.07 |
| Surprise (%) | % |
| Fiscal date ending | Sep 30, 2018 |
| Reported date | Nov 28, 2018 |
| Report time | PRE_MARKET |
| Reported EPS | -0.13 |
| Estimated EPS | -0.13 |
| Surprise | 0 |
| Surprise (%) | 0% |
| Fiscal date ending | Mar 31, 2019 |
| Reported date | Apr 23, 2019 |
| Report time | PRE_MARKET |
| Reported EPS | -52.08 |
| Estimated EPS | -0.15 |
| Surprise | -51.93 |
| Surprise (%) | -34620% |
| Fiscal date ending | Jun 30, 2019 |
| Reported date | Sep 30, 2019 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | -0.05 |
| Surprise | 0.05 |
| Surprise (%) | 100% |
| Fiscal date ending | Sep 30, 2019 |
| Reported date | Nov 27, 2019 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | -0.03 |
| Surprise | 0.03 |
| Surprise (%) | 100% |
| Fiscal date ending | Mar 31, 2020 |
| Reported date | Jun 14, 2020 |
| Report time | POST_MARKET |
| Reported EPS | -999999.9999 |
| Estimated EPS | -999999.9999 |
| Surprise | 0 |
| Surprise (%) | 0% |
| Fiscal date ending | Jun 30, 2020 |
| Reported date | Sep 10, 2020 |
| Report time | POST_MARKET |
| Reported EPS | -44000 |
| Estimated EPS | -200000 |
| Surprise | 156000 |
| Surprise (%) | 78% |
| Fiscal date ending | Sep 30, 2020 |
| Reported date | Dec 2, 2020 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2021 |
| Reported date | Apr 30, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Jun 30, 2021 |
| Reported date | Sep 17, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Sep 30, 2021 |
| Reported date | Dec 1, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2022 |
| Reported date | Apr 26, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Jun 30, 2022 |
| Reported date | Sep 14, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Sep 30, 2022 |
| Reported date | Nov 30, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2025 |
| Reported date | Apr 11, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -36.54 |
| Estimated EPS | 0 |
| Surprise | -36.54 |
| Surprise (%) | % |
| Fiscal date ending | Jun 30, 2025 |
| Reported date | Sep 12, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -15.06 |
| Estimated EPS | 0 |
| Surprise | -15.06 |
| Surprise (%) | % |
| Fiscal date ending | Sep 30, 2025 |
| Reported date | Sep 30, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | |
| Estimated EPS | -0.0001 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Dec 31, 2025 |
| Reported date | Mar 27, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | |
| Estimated EPS | -0.0001 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2026 |
| Reported date | Mar 31, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
| Fiscal date ending | Jun 30, 2026 |
| Reported date | Sep 11, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | 0 |
| Estimated EPS | 0 |
| Surprise | 0 |
| Surprise (%) | % |
Calculation
Growth rate
100.00%
Average
-54,960.527
Maximum
Jun 30, 2026
0
Minimum
Mar 31, 2020
-999999.9999
Median
Sep 30, 2019
0